Thank you for subscribing!
Finfeed Archived Apr 16, 2020
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, has secured CE Mark registration for its PromarkerD Immunoassay kit as an IVD medical device (in vitro diagnostic).
Get expert stock analysis direct in your inbox
Join Our Mailing List